Ocular Therapeutix Fast-Tracks SOL-1 Registrational Trial For Wet AMD, Topline Data Expected In Late 2025

Benzinga · 10/15 11:40
  • SOL-1 is now expected to be enrolled and fully randomized by year-end 2024
  • Topline clinical data from SOL-1 are now expected in Q4 2025